Scarica l'app Stockscreener
73.98
2.66%
-2.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$76.00
Aprire:
$74.5
Volume 24 ore:
549.52K
Relative Volume:
0.42
Capitalizzazione di mercato:
$2.56B
Reddito:
$635.89M
Utile/perdita netta:
$171.92M
Rapporto P/E:
16.98
EPS:
4.357
Flusso di cassa netto:
$151.36M
1 W Prestazione:
+3.86%
1M Prestazione:
+1.04%
6M Prestazione:
-48.40%
1 anno Prestazione:
-34.25%
Intervallo 1D:
$73.09
$75.00
Intervallo di 1 settimana:
$70.90
$78.47
Portata 52W:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
73.98 | 2.63B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
100.68 | 172.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
319.87 | 126.97B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.20 | 106.96B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.03 | 66.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 50.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
Geneos Wealth Management Inc. Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200 - GlobeNewswire Inc.
TransMedics Group Inc (TMDX) Stock Price Quote Today & Current Price Chart | Capital.com EU - Capital.com
What Drove TransMedics' Stellar Q4 2025 Performance - Kavout | AI
Regency Capital Management Inc. DE Purchases Shares of 21,846 TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (TMDX) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr
TransMedics Group (TMDX) awards RSUs and stock options to officer - Stock Titan
Form 4 TransMedics Group Inc For: 14 July By Investing.com - Investing.com India
TransMedics Group (TMDX) CEO receives major RSU and stock option grants - Stock Titan
TransMedics Group Jumps 6.7% Amid Sector-Wide Rally - AlphaStreet
TransMedics (TMDX) Sees 8% Surge, Trading at $76.90 - GuruFocus
TransMedics Group (NASDAQ:TMDX) Shares Up 6.3%Time to Buy? - MarketBeat
TransMedics Group, Inc. (TMDX): A Medical Device Innovator With A 63% Potential Upside - DirectorsTalk Interviews
Candriam S.C.A. Buys 49,580 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (TMDX) Proxy filing Summary - Quartr
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - AOL.com
(TMDX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Where Will TransMedics Group Stock Be in 10 Years? - AOL.com
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why - Stocktwits
TransMedics Group (TMDX) Q1 2026 earnings summary - Quartr
Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut? - Yahoo Finance
TransMedics Group (TMDX) Expands Into Europe, Is The Stock Still Undervalued? - simplywall.st
TransMedics Group (TMDX) Q4 2024 earnings summary - Quartr
10 Best Innovative Healthcare Stocks to Buy Now - Insider Monkey
TransMedics Completes PAD Aviation Investment to Expand in Europe - Yahoo Finance
TransMedics Group outlines organ care growth strategy as US transplant demand rises - ad-hoc-news.de
TransMedics Group completes strategic investment in PAD Aviation - Medical Buyer
Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
TransMedics Group Is Maintained at Outperform by Evercore ISI Group - Moomoo
TransMedics invests in German aviation firm PAD Aviation By Investing.com - Investing.com
TransMedics (TMDX) Secures Strategic Investment in PAD Aviation - GuruFocus
TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH - PR Newswire
PAD Aviation Service GmbH announced that it has received funding from TransMedics Group, Inc. - marketscreener.com
3 Quality Stocks Built For A Pricey Market - Sahm
TMDXTransmedics Group Inc Latest SEC Filings - Finviz
3 Growth Stocks to Buy on the Dip - The Globe and Mail
TransMedics Group Price Target Maintained With a $124.00/Share by Canaccord Genuity - Moomoo
TMDX Reiterated by TD Cowen -- Price Target Maintained at $120 - GuruFocus
Why is TransMedics stock rallying today? By Investing.com - Investing.com Nigeria
TransMedics (TMDX) Sees Growth in Transplant Volumes and Flight Activity - GuruFocus
TD Cowen reiterates TransMedics stock Buy rating on transplant growth By Investing.com - Investing.com Canada
TransMedics: The Margins Must Recover (NASDAQ:TMDX) - Seeking Alpha
Reasons to Retain TransMedics Stock in Your Portfolio for Now - TradingView
TMDX Maintained by Canaccord Genuity -- Rating Remains Buy - GuruFocus
TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Canaccord Genuity Group - MarketBeat
TransMedics Group (NASDAQ:TMDX) Screens as an Affordable Growth Stock with Strong Momentum - ChartMill
Liquidity Mapping Around (TMDX) Price Events - Stock Traders Daily
Price to sales forward of TransMedics Group, Inc. – NASDAQ:TMDX - TradingView
Price to sales forward of TransMedics Group, Inc. – FWB:8T8 - TradingView
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz - The National Law Review
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
2.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):